SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-042425
Filing Date
2018-08-07
Accepted
2018-08-07 16:01:40
Documents
6
Period of Report
2018-08-07

Document Format Files

Seq Description Document Type Size
1 6-K tv500246_6k.htm 6-K 15486
2 EXHIBIT 99.1 tv500246_ex99-1.htm EX-99.1 284061
3 EXHIBIT 99.2 tv500246_ex99-2.htm EX-99.2 46731
4 EXHIBIT 99.3 tv500246_ex99-3.htm EX-99.3 43591
5 EXHIBIT 99.4 tv500246_ex99-4.htm EX-99.4 35624
6 GRAPHIC image_001.jpg GRAPHIC 5620
  Complete submission text file 0001144204-18-042425.txt   434366
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35892 | Film No.: 18997890
SIC: 2834 Pharmaceutical Preparations